Published in PLOS One on 2026-08-19, this study is presented as an attributed evidence briefing. The excerpts below are the original researchers’ words, reproduced under their Creative Commons Attribution licence. HealthSignal has selected the abstract and, where needed, opening background paragraphs; the complete methods, results, limitations and references remain in the linked paper.
Original authors: James B Collins I V, Mandee Lines, Callee Brooks, Abdulkadir Mohammed, Daniel Hailu, Haileyesus Adam, Atalay Mulu Fentie, Mulugeta Ayalew, Diriba Fufa, Mohammed Mustefa, Tadele Hailu, Mamude Dinikiye Ali, Michael Chargualaf, Vanessa Ayer Miller, Megan Roberts, Kaitlyn Buhlinger, Benyam Muluneh
Source: PLOS One • DOI 10.1371/journal.pone.0345608
Read the complete primary study ↗ · Creative Commons Attribution licence
From the researchers
Abstract
Cancer registries allow for the collection of key data associated with patient demographics, diagnoses, and treatments, making them an essential tool for research aimed to improve the quality of care in patients with cancer. Previously, a pediatric cancer registry did not exist in Ethiopia, and prevented the collection of such data. In order to address this gap, a group of oncology clinicians and implementation scientists from the University of North Carolina worked in collaboration with all five pediatric cancer centers within Ethiopia to identify barriers and facilitators associated with a piloted REDCap registry, provide necessary training, and perform workflow analyses to create one integrated process for a pediatric cancer registry. Based on these analyses, deficiencies in the current process were identified and standard operating procedures were developed for each cancer center to guide data collection. These advancements led to the launch of Ethiopia’s first pediatric hospital based cancer registry.
Introduction
Cancer is a leading cause of death for children and adolescents globally. It is estimated approximately 400,000 children and adolescents are diagnosed with cancer annually with the most common childhood cancers: leukemias, brain cancers, lymphomas, and solid tumors, such as neuroblastoma and Wilms tumors [1]. Cancer is now curable for more than 80% of children who have access to modern treatments and robust supportive care. However, many low- and middle-income countries (LMIC) do not have adequate access to the recent advances in treatment and thus survival rates have lagged [2,3]. In Ethiopia, the eleventh most populous country in the world, there are an estimated 150,000 new cancer cases per year, and cancer accounts for 5.8% of total national mortality [4,5]. However, it is unknown within reasonable certainty how many children in Ethiopia are diagnosed, treated, and potentially survive cancer each year, creating a major gap in care.
In 2018, the World Health Organization (WHO) developed the CureAll initiative with the goal to achieve at least 60% survival for children with cancer globally while simultaneously reducing suffering for every child with cancer. The CureAll framework consists of four pillars (centers of excellence, universal health coverage, regimens for management, and evaluation and monitoring). These pillars, in addition to three enablers (advocacy, leveraged financing, and linked governance), support countries in implementing and strengthening childhood cancer programs [6]. Cancer registries, which fall under the evaluation and monitoring pillar of the CureAll framework, are an essential tool in the collection of demographics, diagnoses, and treatment decisions for cancer patients over a large population. Data collected within registries are important for understanding improvements in treatment and assessment of the impact of quality improvement initiatives. Reliance on passive, electronic registration practices to collect these data is not currently an option in Ethiopia due to the absence of electronic health records and electronic collection systems. At this time, one population-based cancer registry exists in Ethiopia, to collect data only for patients cared for in Addis Ababa [7]. This registry is limited to patients treated within the capital city and focuses on adult patients with cancer.
Reading this evidence
Use the full paper to check the study design, participant selection, comparator and outcome definitions before drawing a practical conclusion. An association does not by itself show cause and effect. A reported performance measure needs its denominator and uncertainty. A finding from a particular facility, sample or time period should retain that scope when it is discussed elsewhere.
This briefing makes the source accessible within the wider research & evidence desk. It does not assess an individual patient or certify a product. When considering relevance to another health system, examine the original authors’ account of context and limitations, then seek local implementation evidence. The related reporting below provides other studies to read alongside this one; it is a topic connection, rather than a claim that their results are directly comparable.
© 2026 James B Collins I V, Mandee Lines, Callee Brooks, Abdulkadir Mohammed, Daniel Hailu, Haileyesus Adam, Atalay Mulu Fentie, Mulugeta Ayalew, Diriba Fufa, Mohammed Mustefa, Tadele Hailu, Mamude Dinikiye Ali, Michael Chargualaf, Vanessa Ayer Miller, Megan Roberts, Kaitlyn Buhlinger, Benyam Muluneh. Excerpts reproduced under CC BY. Selection, formatting and contextual notes by HealthSignal. The researchers are the authors of the source study, not members of HealthSignal’s staff.
Explore connected evidence
- Evidence brief: Satellite clinics to bring pediatric cancer care closer to patients in Ethiopia: Perceived relevance, opportunities and anticipated challenges
- Evidence brief: Prevalence of cancer related fatigue and its associated factors among adult cancer patients in eastern Ethiopia: A cross-sectional study
- Evidence brief: Shared decision-making in Cervical Cancer Care at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: A mixed-methods study


